Your browser doesn't support javascript.
loading
Nuclear Abnormalities in LMNA p.(Glu2Lys) Variant Segregating with LMNA-Associated Cardiocutaneous Progeria Syndrome.
Wilke, Matheus V M B; Wick, Myra; Schwab, Tanya L; Starosta, Rodrigo Tzovenos; Clark, Karl J; Connolly, Heidi M; Klee, Eric W.
Affiliation
  • Wilke MVMB; Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA.
  • Wick M; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905, USA.
  • Schwab TL; Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA.
  • Starosta RT; Department of Molecular Hematology, Mayo Clinic, Rochester, MN 55905, USA.
  • Clark KJ; Division of Medical Genetics and Genomics, Washington University in Saint Louis, Saint Louis, MO 63130, USA.
  • Connolly HM; Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre 90610-000, Brazil.
  • Klee EW; Department of Biochemical and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Genes (Basel) ; 15(1)2024 01 18.
Article in En | MEDLINE | ID: mdl-38255001
ABSTRACT
The LMNA gene encodes lamin A and lamin C, which play important roles in nuclear organization. Pathogenic variants in LMNA cause laminopathies, a group of disorders with diverse phenotypes. There are two main groups of disease-causing variants missense variants affecting dimerization and intermolecular interactions, and heterozygous substitutions activating cryptic splice sites. These variants lead to different disorders, such as dilated cardiomyopathy and Hutchinson-Gilford progeria (HGP). Among these, the phenotypic terms for LMNA-associated cardiocutaneous progeria syndrome (LCPS), which does not alter lamin A processing and has an older age of onset, have been described. Here, we present the workup of an LMNA variant of uncertain significance, NM_170707.2 c. 4G>A, p.(Glu2Lys), in a 36-year-old female with severe calcific aortic stenosis, a calcified mitral valve, premature aging, and a family history of similar symptoms. Due to the uncertainty of in silico predictions for this variant, an assessment of nuclear morphology was performed using the immunocytochemistry of stable cell lines to indicate whether the p.(Glu2Lys) had a similar pathogenic mechanism as a previously described pathogenic variant associated with LCPS, p.Asp300Gly. Indirect immunofluorescence analysis of nuclei from stable cell lines showed abnormal morphology, including lobulation and occasional ringed nuclei. Relative to the controls, p.Glu2Lys and p.Asp300Gly nuclei had significantly (p < 0.001) smaller average nuclear areas than controls (mean = 0.10 units, SD = 0.06 for p.Glu2Lys; and mean = 0.09 units, SD = 0.05 for p.Asp300Gly versus mean = 0.12, SD = 0.05 for WT). After functional studies and segregation studies, this variant was upgraded to likely pathogenic. In summary, our findings suggest that p.Glu2Lys impacts nuclear morphology in a manner comparable to what was observed in p.Asp300Gly cells, indicating that the variant is the likely cause of the LCPS segregating within this family.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Progeria / Cardiomyopathy, Dilated / Cardiomyopathies Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Genes (Basel) Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: CH / SUIZA / SUÍÇA / SWITZERLAND

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Progeria / Cardiomyopathy, Dilated / Cardiomyopathies Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Genes (Basel) Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: CH / SUIZA / SUÍÇA / SWITZERLAND